Daily methylphenidate use slows the growth
of children: a community based study

by
Lisska MC, Rivkees SA.
Department of Pediatrics,
Yale University School of Medicine,
New Haven, CT 06520, USA.
J Pediatr Endocrinol Metab. 2003 Jun;16(5):711-8.1


ABSTRACT

OBJECTIVE: The use of methylphenidate (Ritalin) for treatment of attention deficit/hyperactivity disorder (ADHD) has increased dramatically over the last decade. However, the influence of methylphenidate on growth remains controversial. Our goals were to assess whether methylphenidate, as prescribed in the community setting, influences growth. DESIGN: We examined the growth of 84 patients with ADHD treated with methylphenidate in two large pediatric practices. Height standard deviation (SD) scores of treated children were compared with those of untreated biological siblings. We also analyzed the doses of methylphenidate in relation to changes in growth. RESULTS: We found significant differences in mean height SD scores between treated children and sibling controls after 2 years of treatment. Effects on growth were observed over the broad range of doses used (10-80 mg per day). CONCLUSIONS: Our findings suggest that the prevalence of grow-suppressive effects of methylphenidate is greater than previously suspected.
Concerta
The Ritalin Kid
CNS stimulants
Self-medication
Dopamine uptake
Psychotomimesis
Kids on stimulants
Canine narcolepsy
Genetics and AD/HD
Phenylpropanolamine
Appetite suppressants
Methylphenidate: structure
Ritalin, dopamine and the rat
Dexmethylphenidate (Focalin)
Big Pharma meets Madison Avenue



Refs
and further reading

amphetamines.com
HOME
HedWeb
Nootropics
erythroxylum-coca.com
Cannabis.net
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhappiness?
Utopian Surgery?
The Good Drug Guide
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World